| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/16/2007 | CN1315528C Ginger carminative oral lozenge |
| 05/16/2007 | CN1315527C Externally used cold-evil expelling prepn |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315473C Therapeutic compositions |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |
| 05/15/2007 | US7217800 Peptide leukotriene receptor |
| 05/15/2007 | US7217786 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217730 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 05/15/2007 | US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence |
| 05/15/2007 | US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217710 Pyrazolo-pyrimidine compound; anticancer agents |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217705 synergistic effect; CB1 receptor antagonist is an azetidine compound of given formula such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, and the dopaminergic agent is ropinirole or levodopa for example |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | US7217697 Sodium dependent glucose transporter 1 inhibitors; blocking small intestine absorption of glucose; diabetes |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217692 Complex of a human FOXC2 protein and a FOXC2-interacting protein |
| 05/15/2007 | US7217575 Avidin derivatives and uses thereof |
| 05/15/2007 | US7217565 Contacting, binding to monoclonal antibodies; therapy for central nervous system disorders |
| 05/15/2007 | US7217539 Cell death inducers for mast cells |
| 05/15/2007 | US7217534 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 05/15/2007 | US7217528 isolated antibody that specifically binds to polypeptides for diagnosing, preventing and treating autoimmune, cancer and transplant disorders; wound healing agents |
| 05/15/2007 | US7217524 Method for diagnosing aplasia of corpus callosum |
| 05/15/2007 | US7217457 Mixture of hydrophobic polymer core and nanoparticles; immobilization |
| 05/15/2007 | US7217416 Use of gamma globulin for the topical treatment of lesions of dermatitis |
| 05/15/2007 | US7217413 Use of novel agents inducing cell death in synergy with interferons |
| 05/15/2007 | CA2437844C Method for increasing leptin levels using nicotinic acid compounds |
| 05/15/2007 | CA2399709C Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 05/15/2007 | CA2281944C Methods and compositions for preventing and treating chronological aging in human skin |
| 05/15/2007 | CA2159822C Process for inhibiting the transcription of genes |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/10/2007 | WO2007053406A1 Combinations of antihypertensive and cholesterol lowering agents |
| 05/10/2007 | WO2007052850A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007052849A1 USE OF COMBINATION OF ANTI-ANGIOGENIC SUBSTANCE AND c-kit KINASE INHIBITOR |
| 05/10/2007 | WO2007052843A1 Heterocyclic amide compound and use thereof |
| 05/10/2007 | WO2007052808A1 Hydrazide compound and thrombopoietin receptor activator |
| 05/10/2007 | WO2007052794A1 o-SUBSTITUTED ANILINE DERIVATIVE AND ANTIOXIDANT DRUG |
| 05/10/2007 | WO2007052740A1 Equol level regulator |
| 05/10/2007 | WO2007052641A1 Intestinal immunity activator |
| 05/10/2007 | WO2007052561A1 Method for prevention of myocardial hypertrophy by inhibiting interaction between slim1 and usp, and agent for prevention of myocardial hypertrophy |
| 05/10/2007 | WO2007029642A9 Remedy for osteoporosis with the use of retinoid x receptor-related compound |
| 05/10/2007 | WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy |
| 05/10/2007 | WO2005058290A3 Vitamin e for facilitating the synchronization of circadian rhythm |
| 05/10/2007 | US20070106087 Therapeutic Malonic Acid/Acetic Acid C60 Tri-Adducts of Buckminsterfullerene and Methods Related Thereto |
| 05/10/2007 | US20070105961 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105908 Thiazolimine compound and oxazolimine compound |
| 05/10/2007 | US20070105901 Novel piperidine derivative |
| 05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/10/2007 | US20070105894 Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor |
| 05/10/2007 | US20070105890 Novel condensed imidazole derivative |
| 05/10/2007 | US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea |
| 05/10/2007 | US20070105886 Steroidal compounds for inhibiting steroid sulphatase |
| 05/10/2007 | US20070105883 Novel physiologically active substances pf127oa, b and c substances |
| 05/10/2007 | US20070105868 3-(2-{5-methyl-2-[4-(trifluoromethyl)piperidin-1-yl]-1,3-thiazol-4-yl}ethoxy)phenyl]acetic acid,peroxime proliferator-activated receptor antagonists; side effect reduction; very low toxicity, especially hepatotoxicity; metabolic disorders; antidiabetic agents; anticholesterol agents; antilipemic agents |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105858 Retinoic acid mimetic anilides |
| 05/10/2007 | US20070105843 Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 05/10/2007 | US20070105812 Treating HIV-1 viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine |
| 05/10/2007 | US20070105796 Method for inhibiting telomerase activity and inhibitor thereof |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070104719 Caspase Activated Prodrugs Therapy |
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104679 Induction of differentiation of stem cells, and control of differentiation potency of stem cells |
| 05/10/2007 | DE19681207B4 Therapeutische Verwendung von Rubidiumionen und Zubereitungen Therapeutic Use of rubidium and preparations |
| 05/10/2007 | CA2628014A1 Ortho-substituted aniline derivative and antioxidant drug |
| 05/10/2007 | CA2627598A1 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 05/09/2007 | EP1783491A1 Method of screening vascular smooth muscle cell growth inhibitor and growth promoter |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783216A1 Telomerase-inhibitory ena oligonucleotide |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1783127A1 Novel compound having lipase inhibitory activity |
| 05/09/2007 | EP1783126A2 N-oxides of N-phenyl-2-pyrimidine-amine derivatives |
| 05/09/2007 | EP1783124A1 2-phenylthiophene derivative |
| 05/09/2007 | EP1782849A2 Three-dimensional stromal tissue |
| 05/09/2007 | EP1782838A1 Inhibition of infiltration, and cell killing agent |
| 05/09/2007 | EP1782830A1 Preventive and/or remedy for lower urinary tract diseases containing ep4 agonist |
| 05/09/2007 | EP1782828A1 Progression inhibitor for disease attributed to abnormal accumulation of liver fat |
| 05/09/2007 | EP1782820A1 Method of screening toxin-neutralizing peptide, stx2 inhibitory peptide and vero toxin-neutralizing agent |
| 05/09/2007 | EP1782813A1 The combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 05/09/2007 | EP1782800A2 JAK/STAT pathway inhibitors and the uses thereof |
| 05/09/2007 | EP1781685A1 Therapeutic and diagnostic agents |
| 05/09/2007 | EP1781601A2 Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors |
| 05/09/2007 | EP1781288A2 Modulators of muscarinic receptors |
| 05/09/2007 | EP1551369A4 Combination therapy for treatment of fibrotic disorders |
| 05/09/2007 | EP1501796B1 3-(pyridinyl-amino)-1h-indole-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 05/09/2007 | EP1450799B9 Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers |
| 05/09/2007 | EP1408970B1 Indolines and tetrahydro-quinolines as prodrugs for tumour treatment |
| 05/09/2007 | EP1406883B1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 05/09/2007 | EP1383489B1 Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 05/09/2007 | EP1338651B9 Method of screening remedy for diabetes |